Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Abbvie gets USFDA approval for updated indication statement for Rinvoq for Inflammatory Bowel Disease

Ruchika Sharma14 Oct 2025 11:40 AM IST

North Chicago: AbbVie has received the U.S. Food and Drug Administration (FDA) approval for a supplemental new drug application (sNDA) that...

Boehringer Ingelheim, CDR-Life enter into new agreement to develop autoimmune disease molecule

Boehringer Ingelheim Jascayd tablets approved by USFDA for idiopathic pulmonary fibrosis

Ruchika Sharma14 Oct 2025 11:06 AM IST

Ingelheim: Boehringer Ingelheim has received approval from the U.S. Food and Drug Administration (FDA) for JASCAYD (nerandomilast) tablets as an...

Natco Pharma unveils Everolimus tablets 1mg in US

Natco Pharma to buy significant stakes in South African Drugmaker Adcock Ingram

Ruchika Sharma13 Oct 2025 4:55 PM IST

Johannesburg: India's Natco Pharma is set to buy significant stakes in 135-year-old South African pharmaceutical major Adcock Ingram, as part of...

Tamil Nadu cancels licence of Sresan Pharma, orders shutdown

Ruchika Sharma13 Oct 2025 4:05 PM IST

Chennai: Tamil Nadu-based Sresan Pharmaceuticals, the company behind the adulterated Coldrif cough syrup linked to child deaths in Madhya...

Chemist shop owner among three arrested in Ghaziabad over illegal sale of cancer drugs

ED arrests Himachal Assistant Drug Controller in corruption case

Ruchika Sharma13 Oct 2025 2:47 PM IST

Directorate of Enforcement (ED), Shimla Sub Zonal Office has arrested Nishant Sareen, currently posted as Assistant Drug Controller (HQ), Directorate...

Around 5,000 Small Pharma Units at Risk as Centre Enforces Tougher GMP Norms

Indore pharma unit under fire as inspection flags 216 lapses

Ruchika Sharma13 Oct 2025 1:39 PM IST

Indore: The heartbreaking deaths linked to contaminated Coldrif cough syrup have uncovered serious cracks in pharmaceutical manufacturing standards,...

Dr Reddys, Zydus recall products in US over manufacturing issues

Zydus, Dr Reddy's recall products in US over manufacturing issues

Ruchika Sharma13 Oct 2025 12:00 PM IST

New Delhi: Pharmaceutical giants Dr Reddy's Laboratories and Zydus Lifesciences are recalling products from the U.S. market due to...

Aurobindo Pharma arm Unit IV gets 5 USFDA observations

Biocon gets 1 USFDA observation for Cranbury site

Ruchika Sharma13 Oct 2025 11:00 AM IST

Bangalore: Biocon has announced that its manufacturing site in Cranbury, New Jersey, has received a single observation following a GMP inspection...

JnJ completes acquisition of Halda Therapeutics, its novel platform for cancer treatment

Novo Nordisk to acquire Akero Therapeutics for up to USD 5.2 billion

Ruchika Sharma13 Oct 2025 10:15 AM IST

Denmark: Novo Nordisk has announced that it has entered into a definitive agreement to acquire Akero Therapeutics, Inc., a publicly held...

Lupin unveils Liraglutide Injection in US for diabetes

Lupin gets 1 USFDA observation for Somerset facility

Ruchika Sharma12 Oct 2025 2:45 PM IST

Mumbai: Lupin has announced that the company has received one observation from the U.S. Food and Drug Administration (USFDA) after a Pre-Approval...

CDSCO Panel Clears Bristol Myers Yervoy for Two New Cancer Indications

Bristol myers Squibb to acquire Orbital for USD 1.5 billion

Ruchika Sharma12 Oct 2025 2:00 PM IST

Princeton: Bristol Myers Squibb and Orbital Therapeutics have announced a definitive agreement under which Bristol Myers Squibb will acquire...

Natco Pharma appoints G Vijay Kiran Kumar as VP- Corporate Quality Assurance (Formulations)

Ruchika Sharma12 Oct 2025 1:30 PM IST

Hyderabad: Natco Pharma has announced the appointment of G. Vijay Kiran Kumar as Vice President - Corporate Quality Assurance (Formulations) of the...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok